Hereditary Neuropathy - complex

Gene: AGXT

Green List (high evidence)

AGXT (alanine-glyoxylate aminotransferase, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000172482
EnsemblGeneIds (GRCh37): ENSG00000172482
OMIM: 604285, ClinGen, DECIPHER
AGXT is in 18 panels

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Multi-system oxalate deposition including leading to neuropathy.
Sources: NHS GMS
Created: 30 Mar 2020, 8:21 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hyperoxaluria, primary, type 1, MIM#259900

History Filter Activity

19 Sep 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag clinical trial tag was added to gene: AGXT.

19 Sep 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag treatable tag was added to gene: AGXT.

30 Mar 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: agxt has been classified as Green List (High Evidence).

30 Mar 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: agxt has been classified as Green List (High Evidence).

30 Mar 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: AGXT was added gene: AGXT was added to Hereditary Neuropathy - complex. Sources: NHS GMS Mode of inheritance for gene: AGXT was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: AGXT were set to Hyperoxaluria, primary, type 1, MIM#259900 Review for gene: AGXT was set to GREEN